Brittle diabetes is a term for type 1 diabetes with severe, unpredictable glycemic instability — frequent diabetic ketoacidosis (DKA), severe hypoglycemia, or both. A common modern definition is 4 or more hospital admissions per year for glycemic crises. The term is used less often today because most cases have an identifiable underlying cause that, once treated, restores reasonable stability.
Definition and Terminology
- Historical use: “brittle” described any T1D with marked instability — frequent DKA, severe hypoglycemia, or both.
- Modern definition: 4 or more glycemic crisis admissions per year despite a structured insulin regimen.
- Three patterns:
- Recurrent DKA
- Recurrent severe hypoglycemia
- Mixed pattern
- Prevalence: about 3 per 1,000 people with type 1 diabetes (less common in the modern era of insulin analogs and CGM).
- Demographics: historically reported more in young women aged 15 to 30; now recognized across demographics.
Common Causes
| Cause | Mechanism | Estimated Frequency |
|---|---|---|
| Diabulimia / eating disorder | Intentional insulin omission for weight control | Up to one-third of cases in young women |
| Gastroparesis | Variable food absorption causes insulin-food mismatch | 20 to 30% |
| Insulin absorption variability | Lipohypertrophy, scarring, poor injection technique | 10 to 20% |
| Occult infection | Ongoing infection causes insulin resistance | 5 to 10% |
| Endocrine disorders | Addison’s, hyperthyroidism, growth hormone disorders | 5 to 10% |
| Drug or alcohol use | Direct glucose effects, missed doses | 5 to 15% |
| Factitious / Munchausen | Intentional self-induced crisis | Rare but documented |
| Severe insulin resistance (rare syndromes) | Antibodies, receptor disorders | Rare |
| Truly idiopathic | No identifiable cause after thorough workup | Less than 5% |
Symptoms and Presentation
- Frequent DKA — nausea, vomiting, deep breathing (Kussmaul), abdominal pain, altered mental status.
- Frequent severe hypoglycemia — confusion, seizure, loss of consciousness, often requiring third-party assistance.
- Hypoglycemia unawareness — no warning symptoms before severe hypoglycemia.
- Wide glucose swings — minute-to-minute CGM data show extreme variability.
- Multiple ER visits and hospital admissions.
- Quality of life impact — disability, lost work, social isolation.
- Psychological symptoms — depression, anxiety, sometimes disordered eating.
Diagnostic Workup
- History and review: insulin regimen, technique, sites, storage; meal patterns; psychosocial context.
- Hospital records review: document the pattern and trigger of each crisis.
- Continuous glucose monitoring: baseline 14 to 30 days to characterize variability and identify patterns.
- Gastric emptying study: nuclear medicine scintigraphy to rule out gastroparesis.
- Psychological assessment: screen for depression, anxiety, eating disorders, factitious behavior.
- Endocrine workup: TSH and free T4, AM cortisol or ACTH stimulation test, prolactin, IGF-1.
- Insulin antibodies and C-peptide: in selected cases.
- Injection site exam: palpate for lipohypertrophy.
- Insulin storage check: ask about refrigeration, temperature, expiration.
- Drug and alcohol screening: when indicated by history.
- Infection screen: dental abscess, occult UTI, sinusitis, skin or soft-tissue infections.
Treatment Strategies
| Strategy | How It Helps |
|---|---|
| CGM | Reveals patterns, triggers, hypoglycemia awareness loss |
| Insulin pump (CSII) | Smaller, more precise dosing reduces variability |
| Automated insulin delivery (AID) | Algorithm responds to glucose in real time, reducing extremes |
| Structured eating plan | Reduces meal-related variability |
| Insulin rotation and technique training | Resolves lipohypertrophy-related absorption issues |
| Treat gastroparesis | Diet modification, prokinetic agents |
| Psychotherapy / disordered-eating treatment | Addresses diabulimia and behavioral causes |
| Address infections and hormonal disorders | Removes resistance and instability |
| Pancreas or islet transplantation | Last resort for severely refractory cases |
For more on overall treatment approaches, see our treatment hub.
The Role of Psychological Evaluation
Psychological factors are the single most common reversible contributor in young patients. The assessment is not adversarial — it is part of a comprehensive workup. Common findings include:
- Diabulimia — insulin omission for weight loss; up to one-third of young women with brittle diabetes.
- Major depression — interferes with self-care.
- Anxiety disorders — fear of hypoglycemia leading to chronic hyperglycemia, or vice versa.
- Adjustment disorders — particularly in newly diagnosed or transitioning adolescents.
- Personality disorders or factitious illness — rarer but important to recognize.
- Trauma history and PTSD — affect adherence and self-care.
Effective treatment integrates psychiatric or psychological care with diabetes management.
Living With Brittle Diabetes
- Carry glucagon (nasal Baqsimi or injectable) for severe hypoglycemia rescue.
- Train family, friends, and coworkers to recognize and respond to crises.
- Wear medical identification.
- Use CGM with high/low alarms — alert another person if severely hypoglycemic.
- Keep a structured insulin and meal log.
- Avoid alcohol or use cautiously with food.
- Recognize and treat illness early (sick-day rules).
- Maintain close clinic follow-up — every 1 to 3 months.
Disability Considerations
- Frequent crises can qualify for short-term or long-term disability.
- Driving restrictions may apply if hypoglycemia unawareness is documented (see our CDL drivers and diabetes guide).
- Workplace accommodations under the Americans with Disabilities Act may apply.
- Some occupations (military, commercial aviation) may be restricted; see our military and diabetes guide.
- Document each crisis and intervention for medical and legal records.
Prognosis
- Mortality is higher than in stable T1D, especially due to severe hypoglycemia, DKA-related events, and complications of long-standing variability.
- Quality of life is markedly affected — work, education, relationships.
- Most cases improve substantially with identification and treatment of the underlying cause.
- Cases stabilized with AID systems have dramatically improved outcomes in the past decade.
- Selected refractory cases benefit from pancreas or islet transplantation, with long-term insulin independence in 30 to 60 percent at 5 years.
Differential Diagnosis
Not every unstable diabetes is “brittle.” Consider:
- Newly diagnosed type 1 diabetes in the partial remission (“honeymoon”) phase.
- Type 1 diabetes with poor adherence rather than true brittleness.
- Dawn phenomenon or Somogyi effect patterns mistaken for brittleness.
- Ketosis vs ketoacidosis distinction in repeated ER visits.
- Latent autoimmune diabetes in adults (LADA) misdiagnosed as T2D.
- MODY (rare genetic forms) with atypical course.
Related Reading
See our companion guides on dawn phenomenon vs Somogyi, ketosis vs ketoacidosis, type 1 vs type 2 diabetes, and complications and related conditions.
The Bottom Line
Brittle diabetes is type 1 diabetes with severe glycemic instability — typically defined as 4 or more glycemic crisis admissions per year. It is rare (about 3 per 1,000 T1D), and most cases have an identifiable contributor — eating disorder, gastroparesis, infection, endocrine disorder, or insulin absorption issue. Diagnosis is clinical; workup is multidisciplinary; treatment combines structured insulin therapy with CGM or AID, plus targeted management of the underlying cause. Pancreas or islet transplantation is reserved for severely refractory cases. With modern CGM and AID systems, the population labeled “brittle” is smaller than it was 20 years ago — and outcomes are substantially better.
